Anemia, Refractory, with Excess of Blasts - 175 Studies Found
Completed |
: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies :
|
Completed |
: Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia :
: 2006-01-16 : |
Completed |
: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies :
|
Completed |
: Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T :
|
Terminated |
: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler :
|
Completed |
: Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes :
: 2005-07-19 :
|
Completed |
: Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia :
: 2002-10-03 :
|
Recruiting |
: Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA :
|
Active, not recruiting |
: Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine :
|